Mycoses

Article	Citations
Author Index	58
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	50
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	49
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	48
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	47
	46
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	42
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	41
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	40
Physicians' knowledge of invasive fungal disease in China	39
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	36
Issue Information	34
Emergence of Candida auris in intensive care units in Algeria	33
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	33
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	33
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	31
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	31
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	31
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	29
Issue Information	28
Review Article White Piedra: Review of 131 cases	28
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	28
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	26
Issue Information	25
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	25

Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	24
Issue Information	24
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	23
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	21
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	21
	21
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	21
Issue Information	21
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	21
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	21
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	20
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	20
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	19
Cover Image	19
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	19
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	19
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	19
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	18
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	18
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	18
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	18
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	18
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	17
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	17
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	17
Diagnostic performance of noncultural methods for central nervous system aspergillosis	17
Tinea pedis in underrepresented groups: All of Us database analysis	17
	16
CARD9 mutations in patients with fungal infections: An update from the last 5 years	16
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial	16
	16
	16
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	16
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	15
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	15
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	15
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	15
	15
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	14
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	14
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	14
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	14
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	13
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	13
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	13
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	13
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	13
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	13
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	13
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	13

Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	13
Issue Information	12
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	12
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	12
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	12
	12
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	12
	12
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	12
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	12
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	11
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	11
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	11
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	11
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	11
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	11
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	11
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	11
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	11
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	11
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	10
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	10
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	10
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	10
	10
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections	10
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	10
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	10
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	10
Aspergillus nodules: Natural history and the effect of antifungals	10
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	10
Issue Information	10
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	10
	10
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	9
Expert recommendations for prevention and management of Candida auris transmission	9
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	9
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
	9
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	9
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	9
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Abstracts	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Updated estimation of the burden of fungal disease in Vietnam	8
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
Issue Information	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
	7
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	7
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
Time and cost‐efficient identification of Trichophyton indotineae	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	7
Issue Information	7
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	7
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
Invasive fungal infections in acute and chronic liver impairment: A systematic review	7
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	7

Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population‐Based Cohort	6
Dermatophytes and skin dermatophytoses in Southeast Asia—First epidemiological survey from Cambodia	6
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	6
Epidemiological and Clinical Profile Analysis of Trichophyton mentagrophytesITS Genotype VII Infected Dermatomycosis: An Emerging Sexually Transmitted Pathogen	6
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	6
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	6
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	6
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	6
	6
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	6
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	6
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	6
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment	6
Issue Information	6
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals	6
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	6
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	6
Issue Information	6
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran	6
	6
Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	6
Altered skin fungal and bacterial community compositions in tinea capitis	6
Deep Learning Models for CT Segmentation of Invasive Pulmonary Aspergillosis, Mucormycosis, Bacterial Pneumonia and Tuberculosis: A Multicentre Study	6